Drawing for ALMUS

USPTO serial 85896692

ALMUS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ERVIN, INGA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALMUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cary M. Pumphrey

Cary M. Pumphrey Walgreen Co.104 Wilmot RoadMS1430 - Third FloorDeerfield, IL 60015

Goods and services

ClassDescriptionStatusFirst use
003Nutritional creams for the skin and scalpACTIVE—
005Pharmaceutical preparations for use in the treatment of Crohn's Disease, Ulcerative Colitis, severe eczema, Myasthenia Gravis and transplant rejection; pharmaceutical preparations to treat the gastrointestinal system, the cardiovascular system, the respiratory system, the central nervous system, infection, the endocrine system, the urinary tract, blood, obesity, musculoskeletal and joint disease, eye, ear, nose and oropharynx, insomnia, depression, inflammation, skin, and malignant disease, malignant disease being defined as Acute Lymphoblastic Leukaemia, Hodgkin's Disease, Non-Hodgkin's Lymphomas and other oncological diseases; pharmaceutical preparations for pain relief; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of neurological disorders; antihistamines; sedatives; antiseptics; anticonvulsants; Insecticides; Lice treatment preparations; anaesthetics for surgical and non-surgical use; muscle relaxants; smoking cessation preparations; pharmaceutical preparations for use in nutrition namely for the treatment of vitamin and mineral deficiencies; dietary and nutritional supplements; carbohydrate-based nutritional drink mix for use as a meal replacement; immunosuppressants and immunological products, namely, products to treat autoimmune conditions such as Crohn's Disease, ulcerative colitis, severe eczema, Myasthenia Gravis and transplant rejection; pharmaceutical preparations for decelerating the rate of hair loss; pharmaceutical preparations for promoting hair growth; pharmaceutical preparations and substances used to facilitate the care of women during pregnancy; pharmaceutical preparations and substances used during childbirth; pharmaceutical preparations and substances which aid the recuperative period following childbirth; pharmaceutical preparations and substances used to prevent, alleviate or treat medical conditions related to gynaecological medicine; pharmaceutical preparations and substances used to reduce the likelihood of pregnancy; pharmaceutical preparations and substances used to increase the likelihood of pregnancy; mouth spray for medical useACTIVE—
010Medical apparatus used to diagnose and facilitate the care of women during pregnancy; medical apparatus used during childbirth; medical apparatus which aids the recuperative period following childbirth; medical apparatus used to diagnose, prevent, treat or alleviate medical conditions related to gynaecological medicine; contraceptive apparatus; intra-uterine contraceptive devices; medical apparatus used to either reduce or increase the likelihood of pregnancy; medical devices which monitor a person's ability to breathe out airACTIVE—
030Non-medicated maltodextrins for nutritional useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 13, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 13, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 22, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 21, 2016EX5GSOU EXTENSION 5 GRANTED—
Jun 7, 2016EXT5SOU EXTENSION 5 FILED—
Jun 7, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 16, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 15, 2016EX4GSOU EXTENSION 4 GRANTED—
Jan 7, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 28, 2015EXT4SOU EXTENSION 4 FILED—
Dec 28, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 30, 2015EX3GSOU EXTENSION 3 GRANTED—
Jun 23, 2015EXT3SOU EXTENSION 3 FILED—
Jun 23, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 24, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 19, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 18, 2015EX2GSOU EXTENSION 2 GRANTED—
Feb 12, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 19, 2014EXT2SOU EXTENSION 2 FILED—
Dec 19, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 7, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 5, 2014EX1GSOU EXTENSION 1 GRANTED—
Jun 5, 2014EXT1SOU EXTENSION 1 FILED—
Jun 5, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 12, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 10, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 7, 2013ALIEASSIGNED TO LIE—
Sep 24, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 24, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Sep 24, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 24, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 24, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 21, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 20, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2013DOCKASSIGNED TO EXAMINER—
Apr 12, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 9, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance